# VIJAYA (VIJAYA) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/vijaya

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹1,559
- Change: +3.51%
- As of: 2026-09-18
- 1D return: +3.51%
- 5D return: +4.01%
- 1M return: +4.04%
- Latest complete quarter: fy27_q1

## Faxioms Analysis

_As of 2026-09-18_

### Technical Outlook

As of September 18, 2026, VIJAYA's technical stance is primarily bullish, with the current price of ₹1558.9 trading above key moving averages across daily, weekly, and monthly timeframes. This alignment suggests a consistent upward trend across multiple periods. The daily trend shows a strong bullish SuperTrend at ₹1381.61, with the price well above the 200-day Simple Moving Average (SMA) of ₹1173.37. Weekly and monthly timeframes also exhibit bullish SuperTrends at ₹1214.27 and ₹882.74 respectively, reinforcing the positive outlook. The stock is trading near its recent highs, with the nearest resistance level identified at ₹1573.03, approximately 0.91% above the current price. Key support is noted at ₹1539.57, about 1.24% below the current price. The stock has experienced a recent upward gap on September 17, 2026, indicating positive momentum. However, the presence of a "Hammer" pattern on the monthly timeframe, which can sometimes signal a reversal, warrants attention. The annualized volatility stands at 41%, and the Average True Range (ATR) is 3.59% of the price, indicating moderate risk.

Key watch conditions include monitoring the price action around the nearest resistance level of ₹1573.03. A sustained move above this level could signal further upside. Conversely, a break below the support at ₹1539.57, especially on increased volume, might indicate a short-term pullback. The recent "upward_gap" anomaly on September 17, 2026, suggests immediate buying interest, but the "Hammer" pattern on the monthly chart suggests caution regarding potential consolidation or reversal.

- The stock's current price of ₹1558.9 is above key daily, weekly, and monthly moving averages, indicating a bullish trend across timeframes.
- Nearest resistance is observed at ₹1573.03 (0.91% above current price), with support identified at ₹1539.57 (1.24% below current price).
- A "Hammer" pattern was observed on the monthly timeframe on September 18, 2026, which may signal potential trend changes.
- An "upward_gap" anomaly occurred on September 17, 2026, suggesting recent positive price movement.
- Monitor for breaks above ₹1573.03 for potential continuation or below ₹1539.57 for possible consolidation.

- Hammer
- Morning Star
- Doji
- Bearish Engulfing Reversal
- Outside Bar
- Inside Bar

### News Context

Vijaya Diagnostic Centre is scheduled to trade ex-dividend on September 16, 2026. This means that investors purchasing the stock on or after this date will not be eligible to receive the upcoming dividend payout. Separately, brokerages anticipate that the diagnostics sector, including companies like Vijaya Diagnostic Centre, will experience sustained volume growth through fiscal year 2027. This positive outlook is attributed to stable pricing strategies, robust consumer demand (B2C), and the benefits of operating leverage.

- Vijaya Diagnostic Centre to trade ex-dividend on September 16, 2026.
- Brokerages expect sustained volume growth for the diagnostics sector through FY27.
- Factors supporting sector growth include stable pricing and strong B2C demand.

- Hindustan Copper, Garware Hi-Tech Films, Vijaya Diagnostic Centre among stocks to turn ex-dividend on September 16
- Robust demand, pricing to keep volumes strong for diagnostics sector

### What Changed

As of September 18, 2026, Vijaya Diagnostic Centre's share price has seen an increase to ₹1558.9 from its previous price of ₹1506.1. This marks a recent upward movement in the stock's valuation. No new filings or news developments were reported in the period leading up to this observation date. The company continues its operations on the NSE, with no changes noted in its fundamental context.

- On September 18, 2026, Vijaya Diagnostic Centre's stock price was ₹1558.9.
- The stock price on the preceding day was ₹1506.1.
- No new filings or news were reported as of September 18, 2026.
- The company remains listed on the NSE.

### Official Filings

Vijaya Diagnostic Centre Limited has announced a dividend of ₹2 per share, with a record date of September 16, 2026. This distribution returns capital to shareholders. In a separate development, the company has approved the execution of a Business Transfer Agreement (BTA) for the 100% acquisition of the integrated diagnostic business of Arya Wellness Centre in Guwahati, Assam. This acquisition is structured as a slump sale and is subject to certain conditions precedent. The transaction consideration is approximately ₹46 crore, based on an adjusted FY26 EBITDA valuation of 8-9x. Arya Wellness Centre reported FY26 revenue from operations of ₹260 million, with an EBITDA of ₹56 million and a Profit After Tax (PAT) of ₹25 million. The acquisition is anticipated to be completed around November/December 2026. Additionally, the company appointed Dr. Venkata Naresh Yallapragada as Chief Information Officer (CIO) on September 2, 2026, bringing over 23 years of experience in Healthcare IT leadership.

- Dividend of ₹2 per share declared, with a record date of September 16, 2026.
- Board approved the acquisition of Arya Wellness Centre's diagnostic business in Guwahati, Assam, on September 11, 2026.
- Acquisition consideration is approximately ₹46 crore.
- Arya Wellness Centre reported FY26 revenue of ₹260 million and EBITDA of ₹56 million.
- Appointment of Dr. Venkata Naresh Yallapragada as Chief Information Officer effective September 2, 2026.

- SERIES:EQ |PURPOSE:DIVIDEND - RS 2 PER SHARE |FACE VALUE:1 |RECORD DATE:16-Sep-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
- Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026. (Approval for execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on a slump sale basis subject to the fulfilment of Conditions Precedent (CPs) and other terms and conditions as set out in the BTA. |SUBJECT: Outcome of Board Meeting
- VIJAYA DIAGNOSTIC CENTRE LIMITED has informed the Exchange regarding Acquisition (including agreement to acquire) |SUBJECT: Acquisition (including agreement to acquire)-XBRL
- Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam.". |SUBJECT: Press Release
- Vijaya Diagnostic Centre Limited has informed the Exchange about General Updates - Investor Presentation - 100% Acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Asssam. |SUBJECT: General Updates
- AS ON DATE : 30-Jun-2026 | PR_AND_PRGRP: 52.51 | PUBLIC_VAL: 47.49 | EMPTR: 0 | NDS_REVISED_STATUS: Revised | SUBMISSION_DT: 17-Jul-2026 | REVISION_DT: 07-Sep-2026
- VIJAYA DIAGNOSTIC CENTRE LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
- Vijaya Diagnostic Centre Limited has informed the Exchange about change in Management |SUBJECT: Change in Management

### Fundamentals

Vijaya Diagnostic Centre reported a consistent upward trend in its revenue from operations over the observed periods. Revenue grew from ₹205.21 crore in Q3 FY2025-26 to ₹230.98 crore in Q1 FY2026-27. This top-line growth was accompanied by an increase in Profit Before Tax, which rose from ₹58.22 crore in Q3 FY2025-26 to ₹70.94 crore in Q1 FY2026-27. The company's Profit Loss for the Period also showed a positive trajectory, increasing from ₹43.18 crore in Q3 FY2025-26 to ₹53.10 crore in Q1 FY2026-27. While revenue and profit have grown, Finance Costs have also increased, from ₹8.59 crore in Q3 FY2025-26 to ₹11 crore in Q1 FY2026-27, indicating a rise in borrowing costs or debt levels. Other Expenses have also seen a sequential increase. The Tax Expense has moved in line with Profit Before Tax.

Key monitoring areas include the sustained growth in revenue and profitability, and the management of increasing finance costs and other operating expenses. Investors should observe how the company's revenue growth translates into operating leverage and impacts its net profit margins amidst rising costs.

- Revenue From Operations increased from ₹205.21 crore in Q3 FY2025-26 to ₹230.98 crore in Q1 FY2026-27.
- Profit Loss For Period grew from ₹43.18 crore in Q3 FY2025-26 to ₹53.10 crore in Q1 FY2026-27.
- Profit Before Tax rose from ₹58.22 crore in Q3 FY2025-26 to ₹70.94 crore in Q1 FY2026-27.
- Finance Costs increased from ₹8.59 crore in Q3 FY2025-26 to ₹11 crore in Q1 FY2026-27.
- Tax Expense increased from ₹15.05 crore in Q3 FY2025-26 to ₹17.84 crore in Q1 FY2026-27.

### Bull Case

Vijaya Diagnostic Centre's stock shows a constructive technical setup across multiple timeframes. The daily, weekly, and monthly trends are all indicated as bullish, with the Supertrend indicator suggesting upward momentum. This is further supported by positive returns over various periods, including a significant 66% return over the last six months and a 50% year-to-date return. The stock is trading above its 20-day, 50-day, and 200-day Simple Moving Averages (SMAs) and Exponential Moving Averages (EMAs), indicating short-to-medium term strength. Nearest resistance levels are observed around ₹1573.03 and ₹1575.5, while support is identified near ₹1539.57.

- The stock exhibits a bullish trend across daily, weekly, and monthly timeframes, as indicated by the Supertrend indicator.
- Recent performance shows a 66% return in the last six months and a 50% year-to-date return.
- The stock is trading above key moving averages (20-day, 50-day, 200-day SMAs and EMAs), suggesting positive momentum.
- The company is scheduled to go ex-dividend on September 16, 2026.

- Hindustan Copper, Garware Hi-Tech Films, Vijaya Diagnostic Centre among stocks to turn ex-dividend on September 16
- Robust demand, pricing to keep volumes strong for diagnostics sector

### Bear Case

While the diagnostics sector generally shows robust demand and pricing power, specific company performance may face constraints. The company's stock has experienced significant price appreciation over the past year, with a year-to-date return of 0.5 and a 6-month return of 0.66. However, the current price is trading near a resistance level, with the nearest identified resistance at ₹1573.03, which is 0.91% above the current price. The stock also exhibits notable volatility, with an annualized volatility of 0.41 and a maximum drawdown of -0.31 observed historically. The Average True Range (ATR) as a percentage of the price is 3.59, indicating potential for significant price swings.

- The stock price is approaching a resistance level at ₹1573.03, which is 0.91% higher than the current price as of September 18, 2026.
- The company's stock has shown a year-to-date return of 0.5 and a 6-month return of 0.66, indicating a strong upward trend.
- Annualized volatility stands at 0.41, suggesting a degree of price fluctuation.
- The Average True Range (ATR) is 3.59% of the current price, which may signal potential for price movement.

- Hindustan Copper, Garware Hi-Tech Films, Vijaya Diagnostic Centre among stocks to turn ex-dividend on September 16
- Robust demand, pricing to keep volumes strong for diagnostics sector

### FAQs

**What is the company's recent corporate action regarding an acquisition?**

On September 11, 2026, Vijaya Diagnostic Centre Limited announced its Board of Meeting's approval for the execution of a Business Transfer Agreement (BTA). This agreement is for the 100% acquisition of the integrated diagnostic business undertaking of Arya Wellness Centre, located in Guwahati, Assam, on a slump sale basis, subject to the fulfillment of certain conditions.

**When is the ex-dividend date for Vijaya Diagnostic Centre, and what is the dividend amount?**

The ex-dividend date for Vijaya Diagnostic Centre is September 16, 2026. The company will pay a dividend of ₹2 per share, with a face value of ₹1.

**What are the recent price trends and support/resistance levels for Vijaya Diagnostic Centre?**

As of September 18, 2026, Vijaya Diagnostic Centre's stock is trading at ₹1558.9. Technical indicators show a bullish trend on daily, weekly, and monthly timeframes. Key support levels are identified at ₹1539.57, ₹1481.43, ₹1447.97, and ₹1389.83. Nearest resistance levels are observed at ₹1573.03 and ₹1575.5.

**How has Vijaya Diagnostic Centre performed over different periods?**

As of September 18, 2026, Vijaya Diagnostic Centre has shown the following returns: 4% in the last year (return_1y), 66% in the last six months (return_6m), and 19% in the last three months (return_3m). Year-to-date, the return is 50% (return_ytd).

- Hindustan Copper, Garware Hi-Tech Films, Vijaya Diagnostic Centre among stocks to turn ex-dividend on September 16
- Robust demand, pricing to keep volumes strong for diagnostics sector
- SERIES:EQ |PURPOSE:DIVIDEND - RS 2 PER SHARE |FACE VALUE:1 |RECORD DATE:16-Sep-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
- Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026. (Approval for execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on a slump sale basis subject to the fulfilment of Conditions Precedent (CPs) and other terms and conditions as set out in the BTA. |SUBJECT: Outcome of Board Meeting
- VIJAYA DIAGNOSTIC CENTRE LIMITED has informed the Exchange regarding Acquisition (including agreement to acquire) |SUBJECT: Acquisition (including agreement to acquire)-XBRL
## Technical analytics

- As of: 2026-09-18
- Daily trend: Moderate Uptrend
- Weekly trend: Moderate Uptrend
- Pivot point: ₹1,481.43
- Risk regime: Price Risk Requires Attention

### Support levels
- 1334.05
- 1303.2
- 1285.55

### Resistance levels
- 1575.5
- 1573.0333333333333
- 1631.1666666666665

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | +3.51% |
| return_10 | +3.55% |
| return_1m | +4.11% |
| return_1y | +49.12% |
| return_20 | +4.04% |
| return_3m | +19.40% |
| return_5 | +4.01% |
| return_6m | +66.16% |
| return_since_start | +46.69% |
| return_ytd | +49.55% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | elevated_risk |
| label | Price risk requires attention |
| summary | Recent drawdown or price variability is high enough to warrant closer monitoring. |
| maximum_drawdown | -30.63% |
| annualized_volatility | +40.88% |

## Quarterly financials

- Latest complete quarter: fy27_q1

# Revenue Growth Outpaces Operating Expenses, Lifting Profit; Finance Costs Rise Sharply

Vijaya Diagnostic Centre reported revenue of ₹230.98 crore for the first quarter of fiscal 2026-27, marking a 22.8% increase compared to the same quarter a year earlier. Profit after tax grew faster, rising 37.6% to ₹53.10 crore. This acceleration was supported by other operating expenses growing at a slower pace than revenue, which lowered their share of total sales. At the same time, finance costs climbed sharply, adding to the period's overall expense load.

## Revenue Growth Continues
Revenue has increased in each of the last five consecutive quarters, moving from ₹188.05 crore in the year-ago period to ₹230.98 crore currently. The latest quarter saw a sequential rise of 5.3% from the preceding quarter's ₹219.38 crore, following a 6.9% sequential increase in the quarter before that. The year-on-year expansion of 22.8% represents the highest absolute revenue level recorded in the available quarterly sequence.

## Profit Expansion and Expense Trends
Profit before tax rose 35.9% year-on-year to ₹70.94 crore, outpacing the top-line growth. A key factor in this margin expansion was the behavior of other operating expenses, which totaled ₹69.37 crore. These expenses grew 12.8% compared to the year-ago quarter, significantly lagging behind revenue growth. Consequently, other expenses fell as a proportion of revenue, declining from 32.7% to 30.0%. The effective tax rate shifted slightly lower, from 26.1% to 25.2%, allowing profit after tax to reach ₹53.10 crore.

## Rising Finance Costs
Finance costs increased to ₹11.00 crore in the quarter, up 46.9% from ₹7.49 crore a year earlier and 18.0% from the previous quarter's ₹9.32 crore. This marks the fastest growth rate among the expense categories with comparable year-on-year data. As a share of revenue, finance costs expanded from 4.0% to 4.8%. While the absolute year-on-year increase of ₹3.51 crore remains smaller than the ₹42.93 crore revenue gain, the rapid pace of growth stands out within the quarter's expense profile.

## Key Takeaway
Revenue expanded by 22.8%, while other operating expenses grew more slowly, lifting profit margins. Profit after tax increased by 37.6%, supported by this expense leverage and a slightly lower effective tax rate. Finance costs, however, rose sharply by nearly 47%, increasing their share of revenue and representing a notable shift in the company's cost structure for the quarter.

### Ratios

## Official filings

- 2026-09-15 — Corporate Action Notice: Vijaya Diagnostic Centre Limited - Ex-Date: 16-Sep-2026 — [Official attachment](https://www.nseindia.com/companies-listing/corporate-filings-actions)
- 2026-09-11 — Agreement Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_11092026195905_Stx_BM_Outcome_Acquisition_Signed.pdf)
- 2026-09-11 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/REG30_Restructuring_19532_WebXMLFile_20260911_200716296.xml)
- 2026-09-11 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/REG30_Restructuring_19532_WebXMLFile_20260911_201212136.xml)
- 2026-09-11 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/REG30_Restructuring_19532_WebXMLFile_20260911_201241773.xml)
- 2026-09-11 — Press Release: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_11092026204548_Stx_VDCL_PR_Signed.pdf)
- 2026-09-11 — Earnings Presentation: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_11092026205743_Stx_VDCL_Inv_Pres_Signed.pdf)
- 2026-09-08 — Shareholding Disclosure: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SHP_1721991_07092026123813_WEB.xml)
- 2026-09-02 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_19532_WebXMLFile_20260902_175016020.xml)
- 2026-09-02 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_02092026182029_Stx_Int_S.pdf)
- 2026-09-02 — Management Change: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_02092026182426_Stx_Int_S.pdf)
- 2026-09-02 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_02092026184953_Investor_Meet_Intimation.pdf)
- 2026-08-27 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_27082026125839_Stx_Intimation_Signed.pdf)
- 2026-08-26 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/NOTICE_OF_SHAREHOLDERS_MEETINGS_19532_WebXMLFile_20260826_172058307.xml)
- 2026-08-26 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_26082026172536_Stx_Intimation_AGM_notice_M.pdf)
- 2026-08-26 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_26082026173847_Stx_Intimation_Record_date.pdf)
- 2026-08-26 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_26082026174157_Stx_Intimation_Weblink.pdf)
- 2026-08-26 — Management Change: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_ROID_97184_KMP_Doc.zip)
- 2026-08-26 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_19532_WebXMLFile_20260826_181056355.xml)
- 2026-08-26 — Management Change: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_26082026181742_Stx_intimation_merged.pdf)
- 2026-08-26 — Management Change: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_26082026181257_Stx_intimation_merged.pdf)
- 2026-08-25 — Annual Report: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/annual_reports/AR_30671_VIJAYA_2025_2026_A_7192773_26082026173234.pdf)
- 2026-08-21 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_21082026160158_Stx_Intimation_Voting_Results.pdf)
- 2026-08-21 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_19532_WebXMLFile_20260821_190726296.xml)
- 2026-08-21 — Generic Announcement: Vijaya Diagnostic Centre Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/VIJAYA_21082026191728_Stx_Intimation_Letter.pdf)

## News and market events

- 2026-09-15 — BUSINESSTODAY: **Hindustan Copper, Garware Hi-Tech Films, Vijaya Diagnostic Centre among stocks to turn ex-dividend on September 16** — Hindustan Copper, Garware Hi-Tech Films, Vijaya Diagnostic Centre, Vinati Organics, VST Tillers Tractors, Bannari Amman Sugars, Indo Tech Transformers, Eldeco Housing & Industries, TANFAC Industries, ex-dividend stocks, dividend stocks, September 16 ex-dividend, highest dividend stocks, final dividend, dividend record date — [Source](https://www.businesstoday.in/markets/stocks/story/hindustan-copper-garware-hi-tech-films-vijaya-diagnostic-centre-among-stocks-to-turn-ex-dividend-on-september-16-555645-2026-09-15)
- 2026-09-13 — BUSINESS: **Robust demand, pricing to keep volumes strong for diagnostics sector** — Brokerages expect listed diagnostics majors to maintain volume growth through FY27, helped by stable pricing, B2C demand and operating leverage — [Source](https://www.business-standard.com/markets/news/markets-news-robust-demand-pricing-to-keep-volumes-strong-for-diagnostics-126091300223_1.html)
- 2026-09-01 — Mint: **Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today —1 September 2026** — Breakout stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks to buy today —Lumax AutoTechnologies, Vijaya Diagnostic Centre, Tamilnad Mercantile Bank, EPL, and Sansera Engineering. — [Source](https://www.livemint.com/market/stock-market-news/breakout-stocks-to-buy-or-sell-sumeet-bagadia-recommends-five-shares-to-buy-today-1-september-2026-11788224482286.html)
- 2026-08-10 — CNBC-TV18: **Sensex Today | Stock Market LIVE Updates: Nifty around 24,600; Paytm shares jump 8%** — Sensex Today | Stock Market LIVE Updates: We are at the halfway mark of the first day of trade, and the markets are trading in a volatile space, as the Nifty index remains cautious. The index is looking to hold onto the 24,500 mark. The Nifty Bank is also under pressure, down 100 points. SBI, Adani Ports and HDFC Life are the top laggards. — [Source](https://www.cnbctv18.com/market/stock-market-live-updates-sensex-nifty-50-today-oil-banks-midcaps-bajaj-fin-pfc-kaynes-ola-bharat-forge-share-price-liveblog-19965161.htm)
- 2026-08-07 — The Hindu: **Q1 Results 07th Aug Live: SBI, Titan, Hindalco, Hitachi Energy, Power Finance Corporation, Godrej Consumer, Oil India, NLC, Cupid, Kaynes Tech, Ramco Cements, Afcons Infra, Lemon Tree Hotels, Cello to announce Q1 results, LIC, Hero Motocorp, Britannia, Siemens Energy, Muthoot Microfin shares gain, Trent, Premier Energies decline after Q1** — Q1 Results Today, 07th August 2026 Live Updates: Find all the latest Q1 results 2026 updates of Aarti Pharmalabs, Advait Energy Transitions, Amba Enterprises, Afcons Infrastructure, AG Ventures, Akshar Spintex, Alankit, Anuh Pharma, APM Industries, Aqylon Nexus, Archidply Industries, Arihant Superstructures, Arnold Holdings, Aro Granite Industries, Arvind SmartSpaces, Aryan Share and Stock Brokers, Asarfi Hospital, Ashapura Minechem, Ashirwad Steels & Industries, Asit C Mehta Financial Services,... — [Source](https://www.thehindubusinessline.com/markets/q1-results-today-live-updates-sbi-titan-hindalco-power-finance-corporation-godrej-consumer-oil-india-nlc-kaynes-tech-ramco-cements-afcons-infra-lemon-tree-cello-hitachi-lic-trent-results-07-august-202/article71313123.ece)
- 2026-08-07 — MONEYCONTROL: **Stocks to Watch Today: Alkem Labs, J Kumar Infra, Dabur, Britannia, Siemens Energy, Shipping Corporation, Vijaya Diagnostic Centre in focus on 7 August** — Stocks to watch, stocks in focus today, stocks in focus, share market today, top stocks, shares in focus today, shares today, today stocks to watch, trending stocks, trending stocks today, markets today, buzzing stocks, stocks today, stock market today,Britannia Industries,Siemens Energy India,Life Insurance Corporation of India,Shipping Corporation of India,Vijaya Diagnostic Centre,Apollo Tyres,Premier Energies,Alkem Laboratories,J Kumar Infraprojects,Aegis Logistics,Aegis Vopak Terminals,Dabur India,Neuland Laboratories,Orient Electric,Shadowfax Technologies,KPIT Technologies,CreditAccess Grameen,Indegene,Bandhan Bank — [Source](https://www.moneycontrol.com/news/business/markets/stocks-to-watch-today-alkem-labs-j-kumar-infra-dabur-britannia-siemens-energy-shipping-corporation-vijaya-diagnostic-centre-in-focus-on-7-august-13997019.html)
- 2026-08-07 — The Hindu: **Sensex today | Stock Market Live: Stock to buy today: Jubilant FoodWorks (₹473.75)** — Sensex, Nifty, Share Prices Live: The stock of Jubilant FoodWorks has been rallying over the past two weeks. On Monday, it broke out of a resistance at ₹456, hit a four-month high of ₹495.10 on Wednesday and has now moderated to ₹473.75. Therefore, traders can go long now at ₹473 and buy more shares if the price drops to ₹460. Place initial stop-loss at ₹430. When the stock hits ₹550, revise the stop-loss to ₹525. On a rally to ₹575, raise the stop-loss to ₹550. Book profits at ₹600. — [Source](https://www.thehindubusinessline.com/markets/sensex-nifty50-today-stock-market-live-updates-7th-august-2026/article71314561.ece)
- 2026-08-06 — CNBC-TV18: **Q1 Results LIVE Updates: Muthoot Microfin profit surges; Fortis Healthcare margin contracts** — Q1 Results LIVE Updates; Trent, Britannia, Lupin, Samvardhana Motherson, Apollo Tyres, Blue Star, Premier Energies, HCC, NCC, PG Electroplast, Emcure Pharma, Firstsource Solutions are some of the many companies that will be reporting their results during the course of Thursday's trading session on Dalal Street. Result reactions today come from PB Fintech, Aurobindo Pharma, Cummins India, GE Vernova T&D, ION Exchange and many others. Watch this space for all the LIVE Q1 result updates, management and brokerage commentary along with stock moves. — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-cummins-ge-vernova-td-pb-fintech-trent-britannia-hero-lupin-samil-pgel-apollo-tyres-sci-ncc-hcc-premier-energies-share-price-liveblog-19962840.htm)
- 2026-07-17 — CNBC-TV18: **Sensex Today | Stock Market LIVE Updates: Nifty extends gains, rises above 24,250 mark** — Sensex Today | Stock Market LIVE Updates: The markets, contrary to indicators, are trading on a strong footing. The Nifty index is surging with gains of over 120 points as it looks to close the week on a high.The Nifty Bank is also trading higher, rising over 200 points, now above 57,800.Jio Fin, Tech Mahindra and Infosys are the top gainers. — [Source](https://www.cnbctv18.com/market/stock-market-live-updates-sensex-nifty-50-today-ril-wipro-tech-mah-jio-fin-federal-bank-havells-it-share-price-liveblog-19947678.htm)

## Business profile

**Strategic vision:** Integrated diagnostic chain providing laboratory and radiology services.

### Business segments
- **Diagnostic Services:** Provides a comprehensive range of diagnostic services, encompassing both laboratory and radiology testing through a network of diagnostic centres.

### Competitive strengths
- Extensive network of diagnostic centres across multiple Indian states.
- Comprehensive range of laboratory and radiology services.
- Experienced team of over 300 specialized doctors.

## Related stocks

- [ABBOTINDIA (Healthcare)](https://faxioms.com/stocks/abbotindia) — +5.50%
- [ACUTAAS (Healthcare)](https://faxioms.com/stocks/acutaas) — +3.86%
- [AJANTPHARM (Healthcare)](https://faxioms.com/stocks/ajantpharm) — +1.61%
- [ALKEM (Healthcare)](https://faxioms.com/stocks/alkem) — +0.14%
- [ANTHEM (Healthcare)](https://faxioms.com/stocks/anthem) — -0.35%

## Freshness and sources

- Data as of: 2026-09-18
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/vijaya
Markdown representation: https://faxioms.com/stocks/vijaya?render=md